Report overview
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients.
This report aims to provide a comprehensive presentation of the global market for Statin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Statin. This report contains market size and forecasts of Statin in global, including the following market information:
Global Statin Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Statin Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Statin companies in 2022 (%)
The global Statin market was valued at US$ 14850 million in 2022 and is projected to reach US$ 16780 million by 2029, at a CAGR of 1.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide. As per the WHO, Europe followed by North America has witnessed highest elevated total cholesterol level worldwide. There has been a significant rise in patients with obesity, cardiovascular diseases and diabetes which in turn is expected to drive the demand for statins worldwide. In North America, over 70% American adults are suffering from LDL cholesterol. As such, demand for effective treatment of LDL cholesterol has led to increased demand of statins globally. Furthermore, increase in healthcare expenditure in emerging regions along with technological advancement, modern healthcare amenities, and various cholesterol related healthcare campaign is expected to boost overall demand for stains worldwide.
We surveyed the Statin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Statin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Statin Market Segment Percentages, by Type, 2022 (%)
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Global Statin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Statin Market Segment Percentages, by Application, 2022 (%)
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others
Global Statin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Statin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Statin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Statin revenues share in global market, 2022 (%)
Key companies Statin sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Statin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Merck
Pfizer
Amgen
Aurobindo Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Statin, market overview.
Chapter 2: Global Statin market size in revenue and volume.
Chapter 3: Detailed analysis of Statin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Statin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Statin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
